What is Bersacapavir used for?

Bersacapavir is being studied as a potential treatment for chronic hepatitis B virus infections and various liver diseases.

Is Bersacapavir approved for use?

No, Bersacapavir is currently an investigational drug in clinical trial phases and has not received formal approval.

Can Bersacapavir treat hepatitis B?

Research is currently looking into whether Bersacapavir can help manage chronic hepatitis B virus infections.

What stage of testing is Bersacapavir in?

Bersacapavir is in Phase 1 and Phase 2 clinical trials, meaning it is still being tested for safety and effectiveness.

Does Bersacapavir affect the liver?

The drug is being investigated specifically for its impact on liver diseases and hepatitis.

What type of drug is Bersacapavir?

Bersacapavir is classified as a small molecule drug.

Bersacapavir | CAS 1638266-40-6 | SBVBIDUKSBJYEF

Loading compound...

Small molecule investigational drug

Bersacapavir is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential to treat chronic hepatitis B virus infections and other liver-related conditions.

How it worksBersacapavir is a small molecule being researched for its ability to target specific biological processes related to hepatitis B virus infection.

Used for

Chronic hepatitis B virus infectionLiver diseaseHepatitis

Conditions

Hepatitis BLiver disease

Class

Small moleculeSmall molecule investigational drugHepatic

How to take

This drug is currently in the investigational stage (Phase 1 and Phase 2) and is not yet approved for general use.

Talk to your doctor

Questions to ask

·Is Bersacapavir a candidate for my hepatitis B treatment?
·What are the risks of participating in a Bersacapavir clinical trial?
·How does Bersacapavir interact with my current liver medications?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)